ArticlemBio2018

Fecal Microbiota Signatures Are Associated with Response to Ustekinumab Therapy among Crohn's Disease Patients.

Matthew K Doherty et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.